In 2013, two novel and powerful markers of CFLD were identified, tissue inhibitor of metalloproteinase-4 (TIMP-4) and Endoglin (homodimer of 180 kDA located on cell surfaces and part of TGF-β receptor complex). Here, ENG is linked to cystic fibrosis-related liver disease.